Star Health: Q4 Profit Soars to ₹111 Cr, Annual Earnings Decline 13.76%
Star Health announced a standalone net profit of ₹111.34 crore for the fourth quarter of FY26, a sharp increase from ₹0.51 crore in the same period last year. However, annual net profit for FY26 declined by 13.76% to ₹556.98 crore.
Financial Results Breakdown
Star Health and Allied Insurance Company Ltd reported its financial results for the quarter and year ending March 31, 2026. The company posted ₹111.34 crore in standalone net profit for Q4 FY26, a significant rise from ₹0.51 crore a year earlier. For the full financial year FY26, standalone net profit decreased by 13.76% to ₹556.98 crore, down from ₹645.86 crore in FY25. This annual decrease was partly linked to a ₹18.63 crore gratuity expense resulting from new labour codes. Despite profit pressures, revenue from operations grew. For Q4 FY26, revenue increased 16.16% year-on-year to ₹5,968.40 crore. Over the full year, revenue grew 10.97% to ₹18,621.92 crore.
Investor Impact and Outlook
These results paint a varied financial picture for Star Health. The strong quarterly profit rebound may indicate operational gains or favorable comparisons to the previous year. Investors will be watching to see if this trend continues. The annual profit decrease points to challenges the company faces, including the impact of regulatory changes like new labour codes on its expenses. The upcoming switch to Ind AS accounting standards next fiscal year will also influence reported financial figures.
Company Profile and Market Context
Star Health operates as India's largest standalone health insurer within a competitive market. For the previous fiscal year, FY25, the company reported a Profit After Tax (PAT) of ₹64,586 Lakhs and revenue of ₹16,78,136 Lakhs. Historically, Star Health has concentrated on expense management and cost control to boost profitability. The company has been preparing for its transition to Ind AS accounting standards, anticipated to change how financial results are presented.
Future Reporting and Focus
Starting next fiscal year, shareholders will see financial performance reported differently with the adoption of Ind AS accounting standards. The company's ability to sustain its quarterly profit momentum and manage operational expenses will be crucial, especially to offset pressures from labour code implementation. Key metrics investors will track include the claims ratio, expense ratio, and premium growth rates across business segments.
Past Scrutiny and Ongoing Risks
Star Health has experienced regulatory scrutiny. In July 2025, the IRDAI imposed a ₹3.39 crore penalty for data and cyber security guideline violations. A significant data breach in August 2024, impacting over 30 million individuals, also raised data protection concerns. Additionally, an elevated claims ratio of 70.3% in FY25 previously affected profitability and continues to be a key area to monitor.
Competitive Landscape
Star Health competes in a busy market. Its rivals include major general insurers such as ICICI Lombard General Insurance, HDFC ERGO General Insurance, SBI General Insurance, and Bajaj Allianz General Insurance. In the specialized health insurance sector, Niva Bupa Health Insurance is also a notable competitor. These companies compete for market share with product innovation, distribution networks, and customer service.
Investor Vigilance Areas
Investors will closely watch the implementation of Ind AS accounting standards and its effect on reported financials. Consistent growth in gross premium written (GPW) and a better expense ratio will signal operational efficiency. Look for management commentary on the long-term effects of new labour codes and strategies for managing unexpected future expenses. The company's capacity to handle its claims ratio alongside industry trends will also be vital for profitability.
